TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | 1 | -3 | -3 | 11 | 21 | 7 | 6 |
| S | %wins | 50 | 50 | 67 | 20 | 20 | 50 | 43 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/17 17:59 | 12/14/17 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | O | VP Busin | S.d | -450 | 35.34 | 0 | -13 | -27 | 34 | D | ||||||||||||||
3/22/17 16:41 | 3/20/17 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | O | VP Busin | S.d | -423 | 34.62 | 8 | -12 | -26 | 34 | D | 5 | 39 | 2 | 5 | 16 | 6 | 5 | 0 | 2 | 2 | 5 | |||
5/13/16 15:32 | 5/11/16 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | H | VP Busin | S | -77 | 26.72 | 6 | -3 | -13 | 19 | D | 45 | -34 | -2 | 21 | -2 | -6 | -2 | -2 | 0 | -9 | -14 | 16 | 17 | |
6/10/15 15:36 | 6/8/15 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | H | VP Busin | S.m | -1,335 | 38.14 | 17 | -35 | -75 | 12 | D | 361 | 86 | 67 | 46 | 17 | -11 | -8 | -2 | 3 | 1 | 4 | -6 | -25 | -34 |
3/19/15 17:41 | 3/18/15 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | H | VP Busin | S.d | -515 | 32.63 | 13 | -16 | -25 | 47 | D | 413 | 108 | 68 | 62 | 36 | 23 | 27 | 3 | -3 | -15 | -4 | 15 | 8 | -27 |
11/12/14 15:53 | 11/11/14 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | O | VP Busin | S | -707 | 23.56 | 10 | -30 | -41 | 44 | D | 329 | 89 | 31 | 16 | 13 | 2 | -7 | 1 | 1 | -2 | -5 | 8 | 76 | 11 |
8/14/14 16:26 | 8/13/14 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Benjamin Howard | MA | O | VP Busin | S.d | -814 | 20.34 | 8 | -40 | -18 | 188 | D | 331 | 98 | 39 | 13 | -13 | -12 | -5 | -5 | 0 | 4 | -2 | 22 | 31 | 79 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |